Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
References to skin brightening, skin lightening, or even-looking skin tone refer to the cosmetic appearance of the skin only
At 35 degrees Celsius (95 degrees Fahrenheit), the tolerance window shrinks to approximately 4 days
This dual-receptor approach enhances insulin secretion, promotes fat metabolism, and may deliver more comprehensive metabolic benefits than GLP-1 activation alone
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (under the brand name Zepbound)
GLUCAGON RECEPTOR Glucagon receptor activity is being studied for its role in energy balance and metabolism
Laboratory studies have demonstrated that GLP-1 receptor activation can reduce the production of pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-), interleukin-6 (IL-6), and interleukin-1 beta (IL-1)
